Ergebnis der Suchanfrage nach Häuser
Newsrooms
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Lamia Messari-Becker is named “Thought Leader 2024“
mehrplanqc awarded EUR 29 million contract from the DLR to build and install scalable neutral-atom quantum computer
mehr- 2
Hellmann takes over contract logistics for Endress+Hauser in North America
mehr - 4
KUBIKx and Ninepointfive invest 3 Million Euros in new communications service for dispatchers
mehr - 2
Die Hyperloop Bremse „Bellow rail brake“ gewinnt die 3D Pioneers Challenge 2022
Ein Dokumentmehr
Spectrum. The most dangerous artwork
The World's Most Dangerous Artwork / Cancer charity Deutsche Krebshilfe (German Cancer Aid), ADP, and the artistic duo LOW BROS welcomed guests to a somewhat unusual gallery opening
mehrNTT DATA Business Solutions AG
Partner itelligence AG links Production Machines with Business Management / itelligence takes part in the Initiative "Open Industry 4.0 Alliance" (FOTO)
mehrDeutsche Energie-Agentur GmbH (dena)
Energy Efficiency Award 2012 honours pioneering industrial companies / German Energy Agency awards international prize to three innovative projects
Berlin (ots) - To honour exemplary energy-efficiency projects in industry and production, Deutsche Energie-Agentur (dena) - the German Energy Agency - has awarded the Energy Efficiency Award 2012 to three pioneering companies. The first prize goes to HARTING, a manufacturer of connection technology, who is ...
mehrBoehringer Ingelheim Receives Positive Recommendation From European Scientific Committee for a New Once Daily Mirapexin(R) (Pramipexole) Formulation for the Treatment Of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - For non-U.S. Healthcare Media Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin(R) / ...
mehrNew Study Results Support Once Daily, Prolonged Release Formulation of Mirapexin(R)/Sifrol(R) (Pramipexole) for the Treatment of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - Data for the Once Daily Mirapexin(R)/Sifrol(R) (Pramipexole) Formulation Under Development Show Efficacy, Safety and Tolerability Outcomes Comparable to the Current Immediate Release Formulation for the Treatment of Parkinson's Disease For non-US Healthcare Media First data ...
mehr